IL33 and atherosclerosis: Therefore, described in murine atherosclerosis models as well as in macrophages as an atheroprotective cytokine, extracellular IL-33 induces proinflammatory, prothrombotic and proangiogenic activation of human ECs, which are processes known to be involved in development and progression of atherosclerosis (Figure 2D).